Taro Pharmaceuticals Ireland Ltd. is in the process of establishing operations in Pharmaceutical Research & Manufacturing at its new location in Roscrea, Co.Tipperary, Ireland.
Taro Pharmaceuticals Industries Ltd. looks forward to diversifying its presence in global markets with the added capabilities and technology at the Roscrea facility.
For employment opportunities, click here.
June 14, 2010
Taro Provides Preliminary First Quarter 2010 Financial Results
More 
June 03, 2010
Taro Receives FDA Approval for Granisetron Hydrochloride Tablets
More
April 30, 2010
Taro Provides Preliminary 2009 Full Year Results
More
April 06, 2010
Taro Receives Patent for T2007, the Company's Second Proprietary Non-Sedating Barbiturate Drug
More
March 25, 2010
Taro Files Audited Financials for the Year Ended December 31, 2006 and Restated Financials for 2005 and 2004
More
March 8, 2010
Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
More
February 18, 2010
Taro Announces Planned Discontinuation of Manufacturing Operations at Its Irish Facility
More
February 4, 2010
Israel Supreme Court Prohibits Sun From Exercising Warrant While Temporary Junction In Affect
More
February 2, 2010
Taro Receives FDA Approval For Levetiracetam Tablets
More